Superbugs & Superdrugs USA

Renaissance Woodbridge Hotel, Iselin, New Jersey (November, 14 - 15, 2016)

With huge interest from leaders in the field including pending confirmations from PAHO/WHO, Astra Zeneca and other senior industry representatives, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Superbugs & Superdrugs event to date.

The programme will hone in on key topics such as public private partnerships, collaboration, R&D, scientific priorities for antibiotic discovery, novel antibacterial therapeutic approaches, antibiotic stewardship, rapid diagnostic tools, combination therapies, resistance prevention, plus much more!

Featured speakers include:

•                     Dr Christopher Houchens, Branch Chief, Antibacterial's Program, BARDA

•                     Dr Rosemarie Aurigemma, Chief, Biodefense Drug Development Section , NIH

•                     Dr Anthony Simon Lynch, Senior Scientific Director, Janssen Research & Development LLC

•                     Dr Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer

•                     Dr Alita Miller, Director of Biology, Entasis Therapeutics

•                     William J Weiss, Director, Pre-Clinical Services, UNT Health Science Center

•                     Dr Domingo Gargallo-Viola, Co-Founder and CSO, ABAC Therapeutics

•                     Dr David Cook, Chief Scientific Officer, Blueberry Therapeutics Ltd

Reasons to join:

•                     Network with industry-leading experts on drug and antimicrobial material developments

•                     Learn new funding opportunities from BARDA and US National plans, to combat antimicrobial resistance

•                     Strengthen your antibiotic pipeline with new insights on microbiome profiling to fight multi-resistant gram negative infections

•                     Hear important discussions on tackling major bottlenecks that hinder development of new antimicrobial drugs with our star panel line-up

•                     Discover novel protein-based biologics for the treatment and prevention of serious bacterial infections from Janssen

Attendee Testimonials From Our Recent Superbugs Show In London:

·         “Great meeting to network and have time to discuss face to face. Key questions and issues. Very collaborative open meeting.” – Roche

·         “It was one of the most useful scientific conferences that I have attended” – BARDA

·         “Good mix of problems such as funding and novel opportunities and success stories” – TNO

·         “I enjoyed attending the meeting this year and wanted to thank you for your efforts in organizing it” – UNT Health Science Centre

·         “I like the mix of early stage technologies and also later stage products being presented” – Sempra Pharmaceuticals

Register early to take advantage of early bird savings at www.superbugs-usa.com/GATE2BIOTECH or contact Teri Arri on email: tarri@smi-online.co.uk, tel: +44 (0)20 7827 6162